Loading...
Synthetic Lethality Targeting Polθ
Drzewiecka, Małgorzata Barszczewska-Pietraszek, Gabriela Czarny, Piotr Skorski, Tomasz Śliwiński, Tomasz
Drzewiecka, Małgorzata
Barszczewska-Pietraszek, Gabriela
Czarny, Piotr
Skorski, Tomasz
Śliwiński, Tomasz
Citations
Altmetric:
Genre
Journal article
Date
2022-06-20
Advisor
Committee member
Department
Microbiology, Immunology, and Inflammation
Permanent link to this record
Collections
Research Projects
Organizational Units
Journal Issue
DOI
http://dx.doi.org/10.3390/genes13061101
Abstract
Research studies regarding synthetic lethality (SL) in human cells are primarily motivated by the potential of this phenomenon to be an effective, but at the same time, safe to the patient’s anti-cancer chemotherapy. Among the factors that are targets for the induction of the synthetic lethality effect, those involved in DNA repair seem to be the most relevant. Specifically, when mutation in one of the canonical DNA double-strand break (DSB) repair pathways occurs, which is a frequent event in cancer cells, the alternative pathways may be a promising target for the elimination of abnormal cells. Currently, inhibiting RAD52 and/or PARP1 in the tumor cells that are deficient in the canonical repair pathways has been the potential target for inducing the effect of synthetic lethality. Unfortunately, the development of resistance to commonly used PARP1 inhibitors (PARPi) represents the greatest obstacle to working out a successful treatment protocol. DNA polymerase theta (Polθ), encoded by the POLQ gene, plays a key role in an alternative DSB repair pathway—theta-mediated end joining (TMEJ). Thus, it is a promising target in the treatment of tumors harboring deficiencies in homologous recombination repair (HRR), where its inhibition can induce SL. In this review, the authors discuss the current state of knowledge on Polθ as a potential target for synthetic lethality-based anticancer therapies.
Description
Citation
Drzewiecka, M.; Barszczewska-Pietraszek, G.; Czarny, P.; Skorski, T.; Śliwiński, T. Synthetic Lethality Targeting Polθ. Genes 2022, 13, 1101. https://doi.org/10.3390/genes13061101
Citation to related work
MDPI
Has part
Genes, Vol. 13, Iss. 6
ADA compliance
For Americans with Disabilities Act (ADA) accommodation, including help with reading this content, please contact scholarshare@temple.edu